Aktie A2DKZ0 JOUNCE THERAPEUTICS, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen Jounce Therapeutics, Inc.

Aktien

A2DKZ0

US4811161011

JNCE

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Graphite Bio, Inc. Announces Executive Changes
JOUNCE THERAPEUTICS, INC. : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year (form 8-K)
Jounce Therapeutics, Inc. Announces Board Changes
Jounce Therapeutics, Inc.(NasdaqGS:JNCE) dropped from NASDAQ Composite Index
Jounce Therapeutics, Inc.(NasdaqGS:JNCE) dropped from S&P Global BMI Index
Jounce Therapeutics, Inc.(NasdaqGS:JNCE) dropped from S&P TMI Index
Jounce Therapeutics Announces Closing of Tender Offer
Concentra Biosciences, LLC completed the acquisition of Jounce Therapeutics, Inc. from Tang Capital Management, LLC and others.
Redx confirms Jounce deal lapses, Tirupati seals deal
Redx Pharma Shares Fall 5% as Merger With Jounce Therapeutics Fails
Termination of Proposed Business Combination of Jounce Therapeutics, Inc. and Redx Pharma plc
JOUNCE THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
Jounce Therapeutics, Inc. Expects Resignation of Elizabeth Trehu as Chief Medical Officer
Sector Update: Health Care Stocks Rise in Late Trading
Sector Update: Health Care Stocks Higher in Afternoon Trading
European Stock Markets Close Higher Monday as First Citizens BancShares' Planned Acquisition of Silicon Valley Bank Assets, Deposits Eases Banking Crisis Fears
Jounce dumps Redx Pharma for acquisition by Concentra; to cut 84% of jobs
Redx Pharma Says Jounce Therapeutics Terminated Merger Deal; Shares Plunge 19%
Jounce Therapeutics Agrees to be Acquired by Concentra Biosciences
Redx Pharma's bid to buy Jounce snubbed by Concentra's higher offer
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2DKZ0 Aktie
  4. Nachrichten Jounce Therapeutics, Inc.
  5. Andere Sprachen